The potential role of cannabinoids in dermatology

被引：80
作者：
Sheriff, Tabrez [1 ]
Lin, Matthew J. [2 ]
Dubin, Danielle [2 ]
Khorasani, Hooman [2 ]
机构：
[1] Royal Prince Alfred Hosp, 50 Missenden Rd, Sydney, NSW, Australia
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF DERMATOLOGICAL TREATMENT | 2020年 / 31卷 / 08期
关键词：
Cannabinoids in dermatology; cannabis; endocannabinoids; cannabidiol; ALLERGIC CONTACT-DERMATITIS; ATOPIC-DERMATITIS; ENDOCANNABINOID SYSTEM; SKIN; RECEPTORS; KERATINOCYTES; ANGIOGENESIS; INFLAMMATION; ACTIVATION; ANANDAMIDE;
D O I：
10.1080/09546634.2019.1675854
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Cannabis is increasingly being used world-wide to treat a variety of dermatological conditions. Medicinal cannabis is currently legalized in Canada, 31 states in America and 19 countries in Europe. The authors reviewed the literature on the pharmacology and use of cannabinoids in treating a variety of skin conditions including acne, atopic dermatitis, psoriasis, skin cancer, pruritus, and pain. Cannabinoids have demonstrated anti-inflammatory, antipruritic, anti-ageing, and antimalignancy properties by various mechanisms including interacting with the newly found endocannabinoid system of the skin thereby providing a promising alternative to traditional treatments.
引用
收藏
页码：839 / 845
页数：7
相关论文
共 48 条
  • [1] The Cannabinoid Receptor CB2 Exerts Antifibrotic Effects in Experimental Dermal Fibrosis
    Akhmetshina, Alfiya
    Dees, Clara
    Busch, Nicole
    Beer, Juergen
    Sarter, Kerstin
    Zwerina, Jochen
    Zimmer, Andreas
    Distler, Oliver
    Schett, Georg
    Distler, Joerg H. W.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (04): : 1129 - 1136
  • [2] Ali A, 2015, PAK J PHARM SCI, V28, P1389
  • [3] [Anonymous], 2018, STAT MED MAR LAWS
  • [4] [Anonymous], 2016, J Dermatol Clin Res
  • [5] Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death
    Armstrong, Jane L.
    Hill, David S.
    McKee, Christopher S.
    Hernandez-Tiedra, Sonia
    Lorente, Mar
    Lopez-Valero, Israel
    Anagnostou, Maria Eleni
    Babatunde, Fiyinfoluwa
    Corazzari, Marco
    Redfern, Christopher P. F.
    Velasco, Guillermo
    Lovat, Penny E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (06) : 1629 - 1637
  • [6] AXIM Biotech, 2016, AXIM BIOT BEG HUM CL
  • [7] Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
    Basu, Sreemanti
    Dittel, Bonnie N.
    [J]. IMMUNOLOGIC RESEARCH, 2011, 51 (01) : 26 - 38
  • [8] Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1-/- mice
    Bilkei-Gorzo, Andras
    Drews, Eva
    Albayram, Oender
    Piyanova, Anastasia
    Gaffal, Evelyn
    Tueting, Thomas
    Michel, Kerstin
    Mauer, Daniela
    Maier, Wolfgang
    Zimmer, Andreas
    [J]. NEUROBIOLOGY OF AGING, 2012, 33 (01) : 200.e11 - 200.e22
  • [9] Cannabinoid receptors as novel targets for the treatment of melanoma
    Blazquez, Cristina
    Carracedo, Arkaitz
    Barrado, Lucia
    Jose Real, Pedro
    Fernandez-Luna, Jose Luis
    Velasco, Guillermo
    Malumbres, Marcos
    Guzman, Manuel
    [J]. FASEB JOURNAL, 2006, 20 (14) : 2633 - +
  • [10] The intersection between cannabis and cancer in the United States
    Bowles, Daniel W.
    O'Bryant, Cindy L.
    Camidge, D. Ross
    Jimeno, Antonio
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (01) : 1 - 10
12345